364 related articles for article (PubMed ID: 33066747)
1. Effect of DNMT3A polymorphisms on CpG island hypermethylation in gastric mucosa.
Takano H; Shibata T; Nakamura M; Sakurai N; Hayashi T; Ota M; Nomura-Horita T; Hayashi R; Shimasaki T; Otsuka T; Tahara T; Arisawa T
BMC Med Genet; 2020 Oct; 21(1):205. PubMed ID: 33066747
[TBL] [Abstract][Full Text] [Related]
2. Effect of polymorphisms of IL-17A, -17F and MIF genes on CpG island hyper-methylation (CIHM) in the human gastric mucosa.
Tahara T; Shibata T; Nakamura M; Yamashita H; Yoshioka D; Okubo M; Yonemura J; Maeda Y; Maruyama N; Kamano T; Kamiya Y; Fujita H; Nakagawa Y; Nagasaka M; Iwata M; Hirata I; Arisawa T
Int J Mol Med; 2009 Oct; 24(4):563-9. PubMed ID: 19724898
[TBL] [Abstract][Full Text] [Related]
3. Increased number of CpG island hypermethylation in tumor suppressor genes of non-neoplastic gastric mucosa correlates with higher risk of gastric cancer.
Tahara T; Shibata T; Nakamura M; Yamashita H; Yoshioka D; Okubo M; Yonemura J; Maeda Y; Maruyama N; Kamano T; Kamiya Y; Fujita H; Nakagawa Y; Nagasaka M; Iwata M; Hirata I; Arisawa T
Digestion; 2010; 82(1):27-36. PubMed ID: 20150736
[TBL] [Abstract][Full Text] [Related]
4. Effect of polymorphisms of IL-1β and TNF-α genes on CpG island hyper methylation (CIHM) in the nonneoplastic gastric mucosa.
Tahara T; Shibata T; Nakamura M; Yamashita H; Yoshioka D; Okubo M; Yonemura J; Kamiya Y; Ishizuka T; Hirata I; Arisawa T
Mol Carcinog; 2011 Nov; 50(11):835-45. PubMed ID: 21400614
[TBL] [Abstract][Full Text] [Related]
5. CpG island promoter methylation (CIHM) status of tumor suppressor genes correlates with morphological appearances of gastric cancer.
Tahara T; Shibata T; Arisawa T; Nakamura M; Yamashita H; Yoshioka D; Okubo M; Yonemura J; Maeda Y; Maruyama N; Kamano T; Kamiya Y; Fujita H; Nakagawa Y; Nagasaka M; Iwata M; Hirata I
Anticancer Res; 2010 Jan; 30(1):239-44. PubMed ID: 20150642
[TBL] [Abstract][Full Text] [Related]
6. Chronic nonsteroidal anti-inflammatory drug (NSAID) use suppresses multiple CpG islands hyper methylation (CIHM) of tumor suppressor genes in the human gastric mucosa.
Tahara T; Shibata T; Yamashita H; Nakamura M; Yoshioka D; Okubo M; Hirata I; Arisawa T
Cancer Sci; 2009 Jul; 100(7):1192-7. PubMed ID: 19432886
[TBL] [Abstract][Full Text] [Related]
7. Influence of MIF polymorphisms on CpG island hyper-methylation of CDKN2A in the patients with ulcerative colitis.
Sakurai N; Shibata T; Nakamura M; Takano H; Hayashi T; Ota M; Nomura-Horita T; Hayashi R; Shimasaki T; Ostuka T; Tahara T; Arisawa T
BMC Med Genet; 2020 Oct; 21(1):201. PubMed ID: 33046033
[TBL] [Abstract][Full Text] [Related]
8. Association between IL-17A, -17F and MIF polymorphisms predispose to CpG island hyper-methylation in gastric cancer.
Tahara T; Shibata T; Nakamura M; Yamashita H; Yoshioka D; Okubo M; Yonemura J; Maeda Y; Maruyama N; Kamano T; Kamiya Y; Fujita H; Nakagawa Y; Nagasaka M; Iwata M; Hirata I; Arisawa T
Int J Mol Med; 2010 Mar; 25(3):471-7. PubMed ID: 20127054
[TBL] [Abstract][Full Text] [Related]
9. CpG island hypermethylation of tumor-suppressor genes in H. pylori-infected non-neoplastic gastric mucosa is linked with gastric cancer risk.
Kaise M; Yamasaki T; Yonezawa J; Miwa J; Ohta Y; Tajiri H
Helicobacter; 2008 Feb; 13(1):35-41. PubMed ID: 18205664
[TBL] [Abstract][Full Text] [Related]
10.
Hayashi T; Shibata T; Nakamura M; Sakurai N; Takano H; Ota M; Nomura-Horita T; Hayashi R; Shimasaki T; Ostuka T; Tahara T; Arisawa T
Genet Test Mol Biomarkers; 2021 Apr; 25(4):255-262. PubMed ID: 33877894
[No Abstract] [Full Text] [Related]
11. Association between cyclin D1 polymorphism with CpG island promoter methylation status of tumor suppressor genes in gastric cancer.
Tahara T; Shibata T; Nakamura M; Yamashita H; Yoshioka D; Okubo M; Yonemura J; Maeda Y; Maruyama N; Kamano T; Kamiya Y; Fujita H; Nakagawa Y; Nagasaka M; Iwata M; Hirata I; Arisawa T
Dig Dis Sci; 2010 Dec; 55(12):3449-57. PubMed ID: 20397048
[TBL] [Abstract][Full Text] [Related]
12. NFKB1 polymorphism is associated with age-related gene methylation in Helicobacter pylori-infected subjects.
Arisawa T; Tahara T; Shiroeda H; Yamada H; Nomura T; Hayashi R; Saito T; Fukuyama T; Otsuka T; Nakamura M; Toshikuni N; Tsuchishima M; Shibata T
Int J Mol Med; 2012 Aug; 30(2):255-62. PubMed ID: 22614238
[TBL] [Abstract][Full Text] [Related]
13. Helicobacter pylori Eradication Modulates Aberrant CpG Island Hypermethylation in Gastric Carcinogenesis.
Choi J; Kim SG; Kim BG; Koh SJ; Kim JW; Lee KL
Korean J Gastroenterol; 2016 Nov; 68(5):253-259. PubMed ID: 27871161
[TBL] [Abstract][Full Text] [Related]
14. Association between polymorphisms in the XRCC1 and GST genes, and CpG island methylation status in colonic mucosa in ulcerative colitis.
Tahara T; Shibata T; Nakamura M; Okubo M; Yamashita H; Yoshioka D; Yonemura J; Hirata I; Arisawa T
Virchows Arch; 2011 Feb; 458(2):205-11. PubMed ID: 21234761
[TBL] [Abstract][Full Text] [Related]
15. Aberrant CpG island hypermethylation in pediatric gastric mucosa in association with Helicobacter pylori infection.
Shin SH; Park SY; Ko JS; Kim N; Kang GH
Arch Pathol Lab Med; 2011 Jun; 135(6):759-65. PubMed ID: 21631269
[TBL] [Abstract][Full Text] [Related]
16. Association of genetic polymorphisms in
Jing W; Otsuka T; Nakamura M; Sakurai N; Takano H; Hayashi T; Ota M; Nomura T; Hayashi R; Shimasaki T; Tahara T; Shibata T; Arisawa T
Oncol Lett; 2019 Mar; 17(3):3482-3488. PubMed ID: 30867787
[TBL] [Abstract][Full Text] [Related]
17. The influence of promoter polymorphism of nuclear factor-erythroid 2-related factor 2 gene on the aberrant DNA methylation in gastric epithelium.
Arisawa T; Tahara T; Shibata T; Nagasaka M; Nakamura M; Kamiya Y; Fujita H; Yoshioka D; Arima Y; Okubo M; Hirata I; Nakano H
Oncol Rep; 2008 Jan; 19(1):211-6. PubMed ID: 18097597
[TBL] [Abstract][Full Text] [Related]
18. MTHFR 677T carrier influences the methylation status of H. pylori-infected gastric mucosa in older subjects.
Tahara T; Shibata T; Nakamura M; Yamashita H; Yoshioka D; Okubo M; Maruyama N; Kamano T; Kamiya Y; Fujita H; Nakagawa Y; Nagasaka M; Iwata M; Takahama K; Watanabe M; Hirata I; Arisawa T
Dig Dis Sci; 2009 Nov; 54(11):2391-8. PubMed ID: 19082889
[TBL] [Abstract][Full Text] [Related]
19. Risk prediction of gastric cancer by analysis of aberrant DNA methylation in non-neoplastic gastric epithelium.
Tahara T; Arisawa T; Shibata T; Wang FY; Nakamura M; Sakata M; Nagasaka M; Takagi T; Kamiya Y; Fujita H; Nakamura M; Hasegawa S; Iwata M; Takahama K; Watanabe M; Hirata I; Nakano H
Digestion; 2007; 75(1):54-61. PubMed ID: 17438355
[TBL] [Abstract][Full Text] [Related]
20. Aberrant DNA methylation in non-neoplastic gastric mucosa of H. Pylori infected patients and effect of eradication.
Perri F; Cotugno R; Piepoli A; Merla A; Quitadamo M; Gentile A; Pilotto A; Annese V; Andriulli A
Am J Gastroenterol; 2007 Jul; 102(7):1361-71. PubMed ID: 17509026
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
